Decoding synovial CD4+ T cell antigen specificities in Rheumatoid Arthritis
解码类风湿性关节炎滑膜 CD4 T 细胞抗原特异性
基本信息
- 批准号:10569878
- 负责人:
- 金额:$ 9.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-01 至 2025-05-01
- 项目状态:未结题
- 来源:
- 关键词:AffectAffinityAllelesAntibodiesAntibody FormationAntibody RepertoireAntigensAreaArginineArthritisAutoantibodiesAutoantigensAutoimmune DiseasesAwardB-Cell ActivationB-LymphocytesBar CodesBindingBioinformaticsBiological AssayCD4 Positive T LymphocytesCell SeparationCellsCellular biologyChronicCitrullineClonal ExpansionClone CellsCoculture TechniquesCollaborationsDataData SetDedicationsDevelopment PlansDiseaseEngineeringEnsureEnzyme-Linked Immunosorbent AssayEnzymesEpitopesFacultyFlow CytometryFrequenciesGeneticGenetic PolymorphismGenetic ScreeningGenetic TranscriptionGoalsHLA-DRB1Helper-Inducer T-LymphocyteHistocompatibility Antigens Class IIHospitalsHumanImmune ToleranceImmune responseImmunologicsImmunologyIndividualInflammatoryJointsKnowledgeLaboratoriesLearningLibrariesLinkLymphocyteLymphocyte BiologyLymphoidMajor Histocompatibility ComplexMapsMediatorMentorsMolecularMolecular TargetPathogenicityPathologicPathologyPatientsPeptidesPeripheralPhage ImmunoPrecipitation SequencingPlayPopulationPositioning AttributePost-Translational Protein ProcessingProcessProductionProteinsRNAResearchResourcesRheumatismRheumatoid ArthritisRheumatologyRoleScientistSerumSiteSpecificitySusceptibility GeneSynovial FluidSynovial MembraneT cell receptor repertoire sequencingT-Cell Antigen Receptor SpecificityT-Cell ReceptorT-LymphocyteTechnologyTestingTissuesTrainingWomanWorkantigen-specific T cellsautoreactivitycareercareer developmentcitrullinated proteinexperienceexperimental studyfunctional genomicsgenome-wideinterestjoint destructionmedical schoolsmemory CD4 T lymphocytenew therapeutic targetnovelpathogenic autoantibodiesperipheral bloodresponsescreeningseropositivetechnology developmenttenure tracktranscriptomicstranslational immunology
项目摘要
Project Summary/Abstract
Rheumatoid arthritis (RA) is a prevalent autoimmune disorder characterized by chronic inflammatory
processes that lead to joint destruction. Immunologically, autoreactive CD4+ T cells play a central role in
disease pathology and activate B cells leading to pathologic lymphoid aggregates within the synovium and
autoantibody production. Although identifying the molecular targets recognized by pathogenic CD4+ T cells is a
critical first step in understanding the molecular basis of RA, we still do not know the antigenic targets for the
vast majority of synovial CD4+ T cells and how such reactivities relate to autoantibody responses. We have
developed a pipeline for CD4+ T cell antigen discovery in RA that relies on a new, cell-based genetic-screening
technology that enables mapping of TCR specificities at genome scale. Based on our preliminary single-cell
transcriptomic data, we have identified several interesting CD4+ T cell populations in synovial fluid that are
clonally expanded and have begun to discover their TCR targets.
This proposal is a five-year research and training plan with a scientific focus on identifying the antigenic targets
of clonally expanded CD4+ T cells from RA synovium and understanding how such antigens relate to
autoantibody responses. We propose in Aim 1 to map the antigenic epitopes and assess the corresponding
HLA-restriction of clonally expanded synovial CD4+ TCRs by performing peptidome-wide antigen discovery
screens. Aim 2 dissects T cell-B cell collaboration in the arthritic joint by interrogating antibody repertoire
binding specificities and performing CD4+ T cell-B cell co-culture assays. Finally in Aim 3, we will engineer an
antigen discovery platform to enable our ability to uncover synovial TCR reactivities against
citrullinated-peptide antigens, a prominent post-translational modification observed in RA.
This study combines cutting-edge genetic and transcriptomic technologies with mechanistic work to critically
evaluate the antigen-specific landscape of RA. It will provide the candidate new training in several scientific
areas to pursue translational immunology research. The candidate’s immediate career development goals are
to gain experience with bioinformatic analysis, antibody profiling technologies, and human immunology assays.
A specific career development plan is described by both the candidate and the mentors, Dr. Stephen Elledge,
an expert in functional genomics and technology development, and Dr. Michael Brenner MD, an expert in
lymphocyte biology and RA, taking advantage of the powerful resources available at Brigham and Women’s
Hospital and Harvard Medical School. The candidate’s long-term career goal is to attain a tenure-track faculty
position leading a diverse group of collaborative scientists dedicated to studying antigen specific immune
responses in rheumatic and autoimmune diseases and their potential applications for therapy.
项目摘要/摘要
类风湿关节炎(RA)是一种普遍的自身免疫性疾病,其特征是慢性炎症
导致关节破坏的过程。在免疫学上,自动反应性CD4+ T细胞在
疾病病理并激活B细胞,导致滑膜内病理淋巴聚集体
自身抗体产生。尽管识别通过致病性CD4+ T细胞识别的分子靶标的是
了解RA的分子基础的关键第一步,我们仍然不知道
绝大多数滑膜CD4+ T细胞以及这种反应率与自身抗体反应之间的关系。我们有
开发了RA中CD4+ T细胞抗原发现的管道,该管道依赖于新的基于细胞的遗传筛查
可以在基因组规模上映射TCR规范的技术。根据我们的初步单细胞
转录组数据,我们已经确定了流体流体中的几个有趣的CD4+ T细胞群
克隆扩展并开始发现其TCR目标。
该建议是一项五年的研究和培训计划,科学重点是识别抗原靶标
从RA滑膜中克隆膨胀的CD4+ T细胞的,并了解此类抗原与
自身抗体反应。我们建议在AIM 1中绘制抗原表位并评估相应的抗原表位
通过执行肽范围的抗原发现,克隆膨胀的滑膜CD4+ TCR的HLA限制
屏幕。 AIM 2通过询问抗体库来剖析Artritic关节中T细胞-B细胞的协作
结合规格和执行CD4+ T细胞-B细胞共培养分析。终于在AIM 3中,我们将设计
抗原发现平台,使我们能够发现滑膜TCR反应性的能力
瓜氨酸肽抗原,一种在RA中观察到的突出的翻译后修饰。
这项研究将尖端的遗传和转录组技术与机械工作结合在一起
评估RA的抗原特异性景观。它将为候选人提供一些科学的新培训
购买翻译免疫学研究的领域。候选人的直接职业发展目标是
获得生物信息学分析,抗体分析技术和人类免疫学测定法。
候选人和导师Stephen Elledge博士都描述了一项特定的职业发展计划。
功能基因组学和技术开发专家,以及迈克尔·布伦纳(Michael Brenner)博士,专家
淋巴细胞生物学和RA,利用Brigham和妇女提供的强大资源
医院和哈佛医学院。候选人的长期职业目标是获得终身教师
职位领导着一组多样化的合作科学家,致力于研究抗原特定的免疫
风湿和自身免疫性疾病的反应及其在治疗中的潜在应用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ayano Christine Kohlgruber其他文献
Ayano Christine Kohlgruber的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
The role of SH2B3 in regulating CD8 T cells in Type 1 Diabetes
SH2B3 在 1 型糖尿病中调节 CD8 T 细胞的作用
- 批准号:
10574346 - 财政年份:2023
- 资助金额:
$ 9.4万 - 项目类别:
Activity-Dependent Regulation of CaMKII and Synaptic Plasticity
CaMKII 和突触可塑性的活动依赖性调节
- 批准号:
10817516 - 财政年份:2023
- 资助金额:
$ 9.4万 - 项目类别:
Alpha-Synuclein-Specific T cells in Parkinson's Disease Pathogenesis
帕金森病发病机制中的α-突触核蛋白特异性 T 细胞
- 批准号:
10752172 - 财政年份:2023
- 资助金额:
$ 9.4万 - 项目类别:
Develop new bioinformatics infrastructures and computational tools for epitranscriptomics data
为表观转录组数据开发新的生物信息学基础设施和计算工具
- 批准号:
10633591 - 财政年份:2023
- 资助金额:
$ 9.4万 - 项目类别:
Dopaminergic mechanisms of resilience to Alzheimer's disease neuropathology
阿尔茨海默病神经病理学恢复的多巴胺能机制
- 批准号:
10809199 - 财政年份:2023
- 资助金额:
$ 9.4万 - 项目类别: